No registrations found.
ID
Source
Brief title
Health condition
Any, requiring ECMO
Sponsors and support
Intervention
Outcome measures
Primary outcome
The first hemostatic complication in the first 14 days of ECMO therapy and the test results of conventional and viscoelastic coagulation tests.
Secondary outcome
Incidence of hemostatic complications and the survival of children on ECMO with and with hemostatic complications.
Background summary
We aim to investigate both conventional coagulation tests (aPTT, anti-Xa, PT) as well as viscoelastic tests (ROTEM/TEG, TGA) and their correlation to hemostatic complications in pediatric extra corporeal membrane oxygenation patients.
Study objective
The addition of viscoelastic tests (ROTEM/TEG and/or TGA) which repflect the whole hemostatic status on a patient might to recognize the level of thrombin formation and fibrinolysis and improve care in pediatric ECMO patients.
Study design
Before initiation ECMO and daily until day 14 of ECMO therapy.
Inclusion criteria
Child (<18 years) on ECMO
Exclusion criteria
> 24 hours on ECMO
No informed consent
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL7624 |
| CCMO | NL66711.078.18 |
| OMON | NL-OMON52557 |